Thalidomide, the notorious drug which caused horrendous birth defects in the 1950s and 1960s, is close to making a comeback as an anticancer drug. Drug firm Celgene of Warren, New Jersey, has applied to European drug authorities for permission to sell thalidomide to treat multiple myeloma, a fatal cancer of the bone marrow. In clinical trials the drug performed well against the disease. It will take Europe seven months or more to reach a verdict on the drug, which will not be prescribed to pregnant women or those considering having children.
To continue reading, today with our introductory offers
Advertisement
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
A quantum state that lasts forever may finally be within our grasp
2
Autism may have two distinct subtypes that vary by brain activity
3
Sperm have been made magnetic to allow IVF inside the body
4
Fully autonomous drones have killed human soldiers for the first time
5
The secrets to keeping your brain sharp in old age
6
Walking shark found in Papua New Guinea is new to science
7
Has the answer to life's origins been hiding in our cells all along?
8
The social media ban is an experiment – here’s how it will be studied
9
Technology is changing our perspective on nature – at every scale
10
Understanding anorexia’s grip on the brain could unlock new therapies
